The Freedom Stack: Chemical Properties
$513.84 · Água BAC grátis + frete grátis nos EUA · Despacho no mesmo dia antes das 14h ET · APENAS PARA USO EM PESQUISA
Comprar Freedom Research Kit22 Citacoes PubMedRevisado por EspecialistasUltima Revisao: julho de 2026
Propriedades Quimicas
| Composition | 1 x GLP3-R 30 mg + 2 x SS-31 50 mg + 2 x KLOW 80 mg |
| Total Peptide Mass | 290 mg across five individually lyophilized vials |
| Format | Five separate vials — not a co-lyophilized blend |
| GLP3-R Component | Retatrutide (LY3437943); synthetic acylated peptide; triple GIP / GLP-1 / glucagon receptor agonist |
| SS-31 Component | Elamipretide (MTP-131); D-Arg-2',6'-dimethyl-Tyr-Lys-Phe-NH2 tetrapeptide; MW ~639.8 g/mol; CAS 736992-21-5 |
| KLOW Component | Per vial: 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV |
| Appearance | White-to-off-white lyophilized powder; KLOW vials carry a pale-blue tint from the GHK-Cu copper complex |
| Classification | Multi-vial research kit |
Identificadores
| Purity Standard | Lot certificate pending |
| Identity Confirmation | Lot certificate pending |
| Counter-Ion | Not reported on the published lot certificate |
| Detection Methods | RP-HPLC, LC-MS/MS, ICP-MS for GHK-Cu copper content |
Editorial Research Note
“Research Summary (Component-Level) No peer-reviewed study has evaluated this five-vial stack as a unit.”
Referencias
- Coskun T, Urva S, Roell WC, et al. Cell Metab. 2022;34(9):1234-1247.e9.
- Urva S, Coskun T, Loh MT, et al. Lancet. 2022;400(10366):1869-1881.
- Jastreboff AM, Kaplan LM, Frías JP, et al. N Engl J Med. 2023;389(6):514-526.
- Rosenstock J, Frias J, Jastreboff AM, et al. Lancet. 2023;402(10401):529-544.
- Szeto HH. British Journal of Pharmacology. 2014;171(8):2029-2050.
- Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;24(8):1250-1261.
- Birk AV, Chao WM, Bracken C, et al. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. British Journal of Pharmacology. 2014;171(8):2017-2028.
- Campbell MD, Duan J, Samuelson AT, et al. Free Radical Biology and Medicine. 2019;134:268-281.
- Sabbah HN, Gupta RC, Kohli S, et al. Circulation: Heart Failure. 2016;9(2):e002206.
- Chiao YA, Zhang H, Sweetwyne M, et al. eLife. 2020;9:e55513.
- Zhao W, Xu Z, Cao J, Fu Q, et al. Journal of Neuroinflammation. 2019;16(1):230.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108.
- Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405-58417.
- Hsieh MJ, et al. Journal of Molecular Medicine. 2017;95(3):323-333.
- Sikiric P, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current Neuropharmacology. 2016;14(8):857-865.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy. 2012;12(1):37-51.
- Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Ageing and Development. 2004;125(2):113-115.
- Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives. Endocrine Reviews. 2008;29(5):581-602.
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, Yan Y, Sitaraman S, Merlin D. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology. 2008;134(1):166-178.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. FDA.gov. Updated 2023.
- World Anti-Doping Agency. The 2025 Prohibited List. WADA. January 1, 2025.
Perguntas de Pesquisa Relacionadas
Related research
The Grand Slam Bundle — Chemical propertiesThe Long Shot — Chemical propertiesThe Radiant Bundle — Chemical properties
Browse all research guides in the Peptide Research Library →Deseja a revisao completa da pesquisa?
Comprar Freedom Research Kit→APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.
